KYTRIL 3 mg/3 ml, solution for injection ampoule, 3 ml
Active ingredients: Granisetron hydrochloride, Granisetron
Commercialized according to BDPMANSM noticeDispensing in France: Prescription only
Solution for injectionampoule, 3 mlintraveineuse
Supply disruption
Package details
Original BDPM fields are shown in French.
- Official name
- KYTRIL 3 mg/3 ml, solution injectable
- Pharmaceutical form
- solution injectable
- Route of administration
- intraveineuse
- Presentation description
- 1 ampoule(s) en verre de 3 ml
- Marketing authorisation holder
- ATNAHS PHARMA NETHERLANDS (PAYS-BAS)
- Reimbursement according to BDPM
- 65%
- Reimbursement conditions
- Ce médicament peut être pris en charge ou remboursé par l'Assurance Maladie dans le cas suivant :<br><br>Chez l'adulte :<br><br>- Prévention des nausées et vomissements de moyenne à forte intensité induits par la chimiothérapie<br>- Prévention des nausées et vomissements de forte intensité induits par la radiothérapie ; JOURNAL OFFICIEL ; 21/11/08
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 Dec 1996
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
69000764CIP73393543CIP133400933935436Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CHLORHYDRATE DE GRANISÉTRONsolution | — | SA |
| GRANISÉTRON BASEsolution | 3,00 mg · une ampoule | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The published catalog does not list other packages of similar medicines.